Literature DB >> 31620214

"AβTau", Lobby or Religion?

José Marco-Contelles1.   

Abstract

A recent review from Prof. Garrett on the causes and cures of Alzheimer's disease prompts the author to insist in that beyond the "AβTau" praxis other alternate, more open therapeutic strategic approaches are possible, and chemistry, medicinal chemistry, should be the starting point, where all the inspiring contributions should find their place to play the match of our health.
Copyright © 2019 American Chemical Society.

Entities:  

Year:  2019        PMID: 31620214      PMCID: PMC6792146          DOI: 10.1021/acsmedchemlett.9b00439

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  4 in total

1.  Why Is Research on Amyloid-β Failing to Give New Drugs for Alzheimer's Disease?

Authors:  Andrew J Doig; Maria P Del Castillo-Frias; Olivia Berthoumieu; Bogdan Tarus; Jessica Nasica-Labouze; Fabio Sterpone; Phuong H Nguyen; Nigel M Hooper; Peter Faller; Philippe Derreumaux
Journal:  ACS Chem Neurosci       Date:  2017-06-06       Impact factor: 4.418

2.  Multitarget drug discovery for Alzheimer's disease: triazinones as BACE-1 and GSK-3β inhibitors.

Authors:  Federica Prati; Angela De Simone; Paola Bisignano; Andrea Armirotti; Maria Summa; Daniela Pizzirani; Rita Scarpelli; Daniel I Perez; Vincenza Andrisano; Ana Perez-Castillo; Barbara Monti; Francesca Massenzio; Letizia Polito; Marco Racchi; Angelo D Favia; Giovanni Bottegoni; Ana Martinez; Maria Laura Bolognesi; Andrea Cavalli
Journal:  Angew Chem Int Ed Engl       Date:  2014-12-11       Impact factor: 15.336

Review 3.  Facts, Results, and Perspectives of the Current Alzheimer's Disease Research.

Authors:  José Marco-Contelles
Journal:  ACS Chem Neurosci       Date:  2019-02-01       Impact factor: 4.418

4.  A methodological critique of the National Institute of Aging and Alzheimer's Association Guidelines for Alzheimer's disease, dementia, and mild cognitive impairments.

Authors:  Mario D Garrett; Ramón Valle
Journal:  Dementia (London)       Date:  2014-03-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.